Dr. Natalia Vladimirovna Volkova

Dr. Natalia Vladimirovna Volkova is a consultant psychiatrist at the Moscow Research Institute of Psychiatry, one of Russia's leading psychiatric research and clinical institutions. With 16 years of experience, she specialises in affective disorders, schizophrenia spectrum conditions, and psychopharmacology. The Moscow Research Institute of Psychiatry has a long tradition of combining clinical care with psychiatric research, and Dr. Volkova's dual clinical and research role reflects the institute's academic mission. She is particularly known for her expertise in treatment-resistant depression and the rational use of complex psychopharmacological regimens in patients with severe mental illness.

Dr. Volkova completed her MD at a leading Russian medical university and subsequently trained in psychiatry, achieving board certification under the Russian system. She earned her PhD at the Moscow Research Institute of Psychiatry, focusing her doctoral research on psychopharmacological approaches to treatment-resistant mood disorders. She has undergone international training in psychopharmacology and biological psychiatry, including participation in European Psychiatric Association (EPA) masterclasses. She maintains active membership of the Russian Society of Psychiatrists and regularly updates her practice through participation in international congress programmes focused on mood disorders and schizophrenia treatment guidelines.

Dr. Volkova's clinical practice centres on the full spectrum of severe mental illness. She manages unipolar and bipolar affective disorders, applying evidence-based pharmacological protocols including antidepressants, mood stabilisers, and augmentation strategies for treatment-resistant cases. Her schizophrenia spectrum expertise encompasses first-episode psychosis management, long-term maintenance with typical and atypical antipsychotics, and clozapine initiation and monitoring for refractory cases. She provides psychopharmacological consultation for complex cases referred from other services, and oversees medication reviews for patients with comorbid physical health conditions affecting psychiatric treatment selection.

The Moscow Research Institute of Psychiatry accepts referrals from international patients, particularly those from CIS countries and Central Asia, seeking specialist psychiatric evaluation and psychopharmacological consultation. Dr. Volkova consults in Russian and English. The institute offers diagnostic assessment, medication review, and structured outpatient psychiatric management. Patients travelling from abroad can arrange pre-visit teleconsultation for clinical history review and to plan their in-person assessment. Moscow's well-connected international airports facilitate access from across the region.

Dr. Volkova has been recognised by the Russian Society of Psychiatrists for her research contributions in psychopharmacology and affective disorders. Her PhD from the Moscow Research Institute of Psychiatry reflects rigorous peer-evaluated research in biological psychiatry. She has presented at national and international psychiatry congresses, including EPA events, and has contributed to peer-reviewed publications on pharmacological management of treatment-resistant depression and schizophrenia spectrum disorders in the Russian-language and international literature.